UNC Health Medication Formulary
QR Code Add Formweb to your mobile device
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Search results for:

tocilizumab

tocilizumab
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Tocilizumab (Actemra) SOLUTION, INTRAVENOUS 20 mg/mL (10 mL)              
Tocilizumab (Actemra) SOLUTION, INTRAVENOUS 20 mg/mL (20 mL)          
Tocilizumab (Actemra) SOLUTION, INTRAVENOUS 20 mg/mL (4 mL)                  
Tocilizumab-aazg (Tyenne) SOLUTION, INTRAVENOUS 20 mg/mL (4 mL)                    
Tocilizumab-aazg (Tyenne) SOLUTION, INTRAVENOUS 20 mg/mL (10 mL)                    
Tocilizumab-aazg (Tyenne) SOLUTION, INTRAVENOUS 20 mg/mL (20 mL)                    

UNC Health

     System Formulary Restriction:

     Use of Actemra injection is restricted to patients who meet one of the following criteria:

  • Inpatient use in patients who are actively enrolled in a study protocol where the study sponsor requires the use of Actemra for adverse drug event treatment
  • Outpatient use in patients with insurance restrictions that do not cover Tyenne

UNC Health IV Compendium Guideline

Med Center
     UNC Medical Center Formulary Restrictions
     Adult Inpatients with COVID-19 Guideline


Last updated: Dec. 30, 2024







This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.